Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2012
07/10/2012CA2360003C Tricyclic inhibitors of poly(adp-ribose) polymerases
07/10/2012CA2291928C Produits anti-cancereux pour le traitement de la mucoviscidose
07/10/2012CA2260265C Novel use of phospholipids of animal origin in therapy and/or dietetics
07/10/2012CA2222601C Plasmid for delivery of nucleic acids to cells and methods of use
07/10/2012CA2211324C Recombinant human alpha-fetoprotein and uses thereof
07/10/2012CA2194172C Neurturin and related growth factors
07/06/2012CA2775393A1 Topical non-aqueous pharmaceutical formulations
07/05/2012WO2012092594A2 Preparations for topical prevention and/or treatment of oral allergic symptoms due to oral contact with fruits and/or vegetables
07/05/2012WO2012092575A1 Topical nitrone spin trap compositions for psoriasis
07/05/2012WO2012092569A2 Compositions comprising immunostimulatory nucleic acids and related methods
07/05/2012WO2012092528A1 Treatment of erectile dysfunction and other indications
07/05/2012WO2012092527A1 Delivery of treatments transdermally for fungal infections and other indications
07/05/2012WO2012092525A1 Cox-2 inhibitors and related compounds, and systems and methods for delivery thereof
07/05/2012WO2012092523A1 Systems and methods for treatment of allergies and other indications
07/05/2012WO2012092504A2 Nanoparticle and surface-modified particulate coatings, coated balloons, and methods therefore
07/05/2012WO2012092486A2 Modified release benzimidazole formulations
07/05/2012WO2012092485A1 Enhancement of placental stem cell potency using modulatory rna molecules
07/05/2012WO2012092484A2 Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
07/05/2012WO2012092471A2 Novel tubulin inhibitors and methods of using the same
07/05/2012WO2012092442A1 Therapeutic compounds and compositions
07/05/2012WO2012092411A2 Phenanthridine macrocyclic hepatitis c serine protease inhibitors
07/05/2012WO2012092409A2 Macrocyclic hepatitis c serine protease inhibitors
07/05/2012WO2012092395A2 Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio) acetic acid and uses thereof
07/05/2012WO2012092382A2 Role of microrna in t cell immune response
07/05/2012WO2012092378A1 Method for treating blepharitis
07/05/2012WO2012092375A1 Method for treating dry eye
07/05/2012WO2012092288A2 Compositions and methods of using crystalline forms of wortmannin analogs
07/05/2012WO2012092202A2 Modulation of side effect profile of 5-alpha reductase inhibitor therapy
07/05/2012WO2012092188A1 Hydrogen bond forming p1 ligands and methods for treating hiv
07/05/2012WO2012092168A1 Fused 6,5 bicyclic ring system p2 ligands, and methods for treating hiv
07/05/2012WO2012092165A1 Transdermal drug delivery system comprising levonorgestrel acetate
07/05/2012WO2012092160A2 Human milk oligosaccharides to promote growth of beneficial bacteria
07/05/2012WO2012092159A1 Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
07/05/2012WO2012092158A1 Human milk oligosaccharides for modulating inflammation
07/05/2012WO2012092157A2 Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
07/05/2012WO2012092156A1 Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
07/05/2012WO2012092155A1 Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
07/05/2012WO2012092154A1 Methods of using human milk oligosaccharides for improving airway respiratory health
07/05/2012WO2012092153A1 Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
07/05/2012WO2012092114A2 Oxidosqualene cyclase as a protein target for anticancer therapeutics
07/05/2012WO2012092103A1 Gemcabene and derivatives for treating pancreatitis
07/05/2012WO2012092035A1 Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate
07/05/2012WO2012091826A1 Cosmetic composition
07/05/2012WO2012091824A1 METHOD OF TREATING SKIN WITH microRNA MODULATORS
07/05/2012WO2012091743A1 Oleanoyl peptide composition and a method of treating skin aging
07/05/2012WO2012091730A2 Indole alkaloid compounds as melanogenesis promoters and uses thereof
07/05/2012WO2012091683A1 Method for extracting silk extract containing lutein
07/05/2012WO2012091625A1 N,ν'-substituted piperazines having combined antiaggregant, anticoagulant and vasodilatory activity, and method for producing same
07/05/2012WO2012091624A1 Physiologically active bis-dialkylamides of phosphoryl-substituted 1,4-dicarboxylic acids and method for producing same
07/05/2012WO2012091610A1 Drug with activity against the herpes virus family
07/05/2012WO2012091598A1 Composition for eliminating toxins from the body and for normalizing the microflora in the intestines
07/05/2012WO2012091593A1 Granulates comprising eslicarbazepine acetate
07/05/2012WO2012091571A2 Combination of components for the prevention and treatment of frailty
07/05/2012WO2012091549A1 Combination of components for the prevention and treatment of frailty
07/05/2012WO2012091542A1 Combination of components for the prevention and treatment of frailty
07/05/2012WO2012091523A2 Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof
07/05/2012WO2012091496A2 siRNA FOR INHIBITION OF Hif1α EXPRESSION AND ANTICANCER COMPOSITION CONTAINING THE SAME
07/05/2012WO2012091425A2 Composition containing a 4-hydroxytamoxifen analog or the pharmaceutically acceptable salts thereof as an active ingredient for preventing or treating diseases associated with metabolic syndrome
07/05/2012WO2012091372A2 Caffeine tape for body slimming
07/05/2012WO2012091357A2 Composition for prevention of nausea or vomiting
07/05/2012WO2012091137A1 GENE THERAPEUTIC AGENT USING TNF-α, CD40L, AND GM-CSF IN COMBINATION
07/05/2012WO2012091136A1 Expression vector, method for producing carrier using same, and use of same
07/05/2012WO2012091118A1 Therapeutic agent for ectopic pregnancy
07/05/2012WO2012091115A1 Acetylene derivative and pharmaceutical application therefor
07/05/2012WO2012091090A1 Antipyretic/analgesic composition
07/05/2012WO2012091049A1 Orally disintegrating tablet
07/05/2012WO2012091010A1 Bicyclic pyrimidine derivative
07/05/2012WO2012090994A1 Ophthalmic solution containing diquafosol, method for producing same, and method for preventing formation of insoluble precipitate
07/05/2012WO2012090939A1 Method for suppressing receptor tyrosine kinase-mediated prosurvival signaling in cancer cells
07/05/2012WO2012090713A1 Concomitant drug for improving cognitive function
07/05/2012WO2012090676A1 Novel medicinal composition and utilization of same
07/05/2012WO2012090505A1 Milk-added, low-calorie black tea beverage
07/05/2012WO2012090479A1 Mcm7 as a target gene for cancer therapy and diagnosis
07/05/2012WO2012090322A1 Patch
07/05/2012WO2012090225A2 Novel cocrystals / molecular salts of metformin with oleoylethanolamide as an effective anti-diabetic + anti- obesity agent
07/05/2012WO2012090224A1 Novel cocrystals / molecular salts of mesalamine to be used as improved anti-inflammatory drug
07/05/2012WO2012090221A1 Novel salts of imatinib
07/05/2012WO2012090220A1 Heterocyclic compounds suitable for the treatment of dyslipidemia
07/05/2012WO2012090218A1 Synergistic effects of the combination of the specific compounds with paracetamol and their effects on various diseases
07/05/2012WO2012090204A1 2 - (2 - phenylethenyl) - 1, 3 -benzothiazine derivatives useful for the treatment cancer
07/05/2012WO2012090201A2 Methods of improving cognitive function
07/05/2012WO2012090179A2 Isoquinoline derivatives as cannabinoid receptor modulators
07/05/2012WO2012090177A2 Cannabinoid receptor modulators
07/05/2012WO2012090170A1 Products for ophtalmic use
07/05/2012WO2012090143A1 Treatment of pain associated with dislocation of basal endometrium
07/05/2012WO2012090136A1 Novel antibacterial compounds
07/05/2012WO2012090124A2 IN SITU GENERATION OF PEROXYCARBOXYLIC ACIDS AT ALKALINE pH, AND METHODS OF USE THEREOF
07/05/2012WO2012090043A1 Novel solid state forms of azilsartan medoxomil and preparation thereof
07/05/2012WO2012090018A1 Cellular hydration compositions containing cyclodextrins
07/05/2012WO2012090005A1 Agonists of toll like receptor for treating cardiovasuclar disease and obesity
07/05/2012WO2012089882A1 Pharmaceutical composition including hyaluronic acid and a zinc compound and corresponding bar on a stick and preparation method
07/05/2012WO2012089876A1 Pyrimidine urea‑derived compound for treating inflammatory diseases
07/05/2012WO2012089828A2 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
07/05/2012WO2012089784A1 Fiber and probiotics for reducing intestinal symptoms related to chronic stress
07/05/2012WO2012089783A1 A nutritional composition comprising fiber and probiotics for reducing stress-related intestinal symptoms
07/05/2012WO2012089782A1 Fiber and probiotics for reducing intestinal symptoms related to stress
07/05/2012WO2012089777A1 Method for the preparation of sodium chondroitin sulphate
07/05/2012WO2012089765A1 Suspension formulations of cetyl myristate and/or cetyl palmitate
07/05/2012WO2012089764A1 A preparation method for suspension of cetyl myristate and/or cetyl palmitate
07/05/2012WO2012089763A1 Separated formulations and granulations of cetyl myristate and cetyl palmitate combination
1 ... 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 ... 7860